| Product NDC: | 25021-823 |
| Proprietary Name: | Haloperidol Lactate |
| Non Proprietary Name: | haloperidol lactate |
| Active Ingredient(s): | 5 mg/mL & nbsp; haloperidol lactate |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 25021-823 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200742 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111024 |
| Package NDC: | 25021-823-10 |
| Package Description: | 1 VIAL in 1 CARTON (25021-823-10) > 10 mL in 1 VIAL |
| NDC Code | 25021-823-10 |
| Proprietary Name | Haloperidol Lactate |
| Package Description | 1 VIAL in 1 CARTON (25021-823-10) > 10 mL in 1 VIAL |
| Product NDC | 25021-823 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | haloperidol lactate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20111024 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | HALOPERIDOL LACTATE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Typical Antipsychotic [EPC] |